INS and congestive heart failure: Because they increase target tissue sensitivity toinsulin without increasing insulin secretion [57], there is no risk ofhypoglycemia, though there is a risk fluid retention in diabetic patients,especially those with coexisting heart failure, or at risk for developing CHF [58].